Orally inhaled and nasal benzodiazepines
AssigneePaion UK Limited
InventorsKarl-Uwe PETERSEN, Derek Jo SAKATA, Thomas STÕHR, John GRAHAM, Brett COOPER, Tatjana BEVANS, Christopher REILLY
Life of this patent
Estimating the term…
Abstract
The present invention relates to Orally Inhaled and Nasal Drug Product (OINDP) comprising a benzodiazepine, in particular remimazolam.
Claims12
A method for inducing or maintaining sedation, hypnosis, anxiolysis, anesthesia, muscle relaxation or treating convulsions in a patient, comprising administering to the patient by inhalation into lungs or sinuses of the patient a pharmaceutical composition comprising remifentanil and a compound of formula (I):
- or a pharmaceutically acceptable salt thereof, and one or more vehicles, carriers or excipients.
An inhalation or intranasal drug delivery device comprising a pharmaceutical composition comprising remifentanil and a compound of formula (I):
- or a pharmaceutically acceptable salt thereof, and one or more vehicles, carriers or excipients.
Dependencies are inferred from the claim text.